Results 191 to 200 of about 181,689 (337)

Impaired physical fitness in pediatric inflammatory bowel disease

open access: yesJournal of Pediatric Gastroenterology and Nutrition, EarlyView.
Abstract Objective There are only a few studies on physical fitness in pediatric inflammatory bowel disease (PIBD). We compared physical fitness in PIBD patients versus healthy controls and analyzed the role of contributing disease‐ and patient‐related factors.
Saija Kantanen   +10 more
wiley   +1 more source

Upadacitinib for difficult‐to‐treat paediatric Crohn's disease

open access: yesJPGN Reports, EarlyView.
Abstract Paediatric‐onset inflammatory bowel disease (IBD) has an enormous impact on healthcare systems as it translates to a lifetime of healthcare. Since the approval of anti‐tumour necrosis factor‐alpha agents, it has become evident that in the long journey of paediatric IBD, there is an absolute need for more treatment options.
N. Nedelkopoulou   +3 more
wiley   +1 more source

Genital Crohn's disease in pediatrics and genetic associations

open access: yesJPGN Reports, EarlyView.
Abstract Genital edema is a rare presentation of Crohn's disease (CD), also known as metastatic CD (MCD). This may precede, co‐occur with, or follow gastrointestinal symptoms and present a diagnostic challenge. We aimed to characterize the features, clinical courses, pathogenesis, and outcomes of patients with MCD to increase understanding and promote ...
Erica Chang   +5 more
wiley   +1 more source

Eosinophilic mesenteric vasculitis presenting as inflammatory bowel disease

open access: yesJPGN Reports, EarlyView.
Abstract Inflammatory bowel disease (IBD), including Crohn's Disease (CD) and ulcerative colitis, is a chronic inflammatory condition affecting the gastrointestinal tract. Treatment for IBD depends on disease severity and can include medical and surgical management.
Razan Alkhouri   +7 more
wiley   +1 more source

Gastrointestinal: Crohn’s disease of the oesophagus [PDF]

open access: bronze, 2000
R D Kimber, I C Roberts-Thomson
openalex   +1 more source

Impact of biologic induction dose and concomitant drugs on anti‐drug antibody formation in a pediatric IBD cohort with high Hispanic representation

open access: yesJPGN Reports, EarlyView.
Abstract Objectives The use of biologic therapy is increasing in pediatric patients with inflammatory bowel disease (IBD). However, efficacy may be compromised by increased drug clearance and anti‐drug antibodies (ADAs). Historically, concomitant immunomodulator therapy (CIT) has been used to prevent ADA formation. Pediatric studies evaluating CIT have
Kenneth Grant   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy